2 ms·
I keep reading about various targetted immunotherapy papers with such amazing potential. It would seem our entire medical establishment is just waiting for sim
by AtlasBarfed 8y ago
I keep reading about various targetted immunotherapy papers with such amazing potential.
It would seem our entire medical establishment is just waiting for simple pills to come out of it, whereas the real "cure" for cancer would seem to be something like a production version of this.
An organized labor pipeline of testing/sequencing of the patient, computational analysis of the specific expression, to specific cancer therapy targeted to the specific cancer case's biochemistry. It wouldn't be cheap, but given the cost of drugs, it could still be efficiently delivered for a similar cost, especially in managed health care systems.
Of course over time, "templates" of therapies for classes of cancer gene expressions would converge. That would be ongoing optimization/efficiency.
But I have no confidence the American health system would deviate from its culture of one size fits all pill pushing or nothing.